Concepedia

Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non–muscle-invasive Bladder Cancer (BRIDGE)

Max Kates, Xiangying Chu, Noah M. Hahn, Eugene J. Pietzak, Angela B. Smith, Daniel H. Shevrin, Paul L. Crispen, Stephen B. Williams, Siamak Daneshmand, Vignesh T. Packiam,

European Urology Focus · 2023 · 48 citations · 8 references

DOIFull text

Open access

Concepts

References

8

Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer

Ryan L. Steinberg, Lewis J. Thomas, Nathan A. Brooks et al. · The Journal of Urology · 2019 · 182 citations

, , +5

Gemcitabine versus bacille Calmette‐Guérin after initial bacille Calmette‐Guérin failure in non‐muscle‐invasive bladder cancer

Giuseppe Di Lorenzo, Sisto Perdonà, Rocco Damiano et al. · Cancer · 2010 · 182 citations · Full text

, , +12

Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

Marc‐Oliver Grimm, Antoine G. van der Heijden, Marc Colombel et al. · European Urology · 2020 · 133 citations

, , +8

Long-Term Survival Outcomes with Intravesical Docetaxel for Recurrent Nonmuscle Invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Therapy

LaMont Barlow, Mitchell C. Benson · The Journal of Urology · 2012 · 121 citations

, , +11

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guérin Instillation Therapy on the Quality of Life in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Prospective, Randomized, Phase II Trial

Paolo Gontero, Marco Oderda, Anja Mehnert et al. · The Journal of Urology · 2013 · 81 citations

, , +10